%0 Journal Article
%A Gerum, Sabine
%A Heinz, Christian
%A Belka, Claus
%A Walter, Franziska
%A Paprottka, Philipp Marius
%A De Toni, Enrico N
%A Roeder, Falk
%T Stereotactic body radiotherapy in patients with hepatocellular carcinoma in a multimodal treatment setting.
%J Strahlentherapie und Onkologie
%V 196
%N 4
%@ 1439-099X
%C Heidelberg
%I Springer Medizin
%M DKFZ-2019-02636
%P 334-348
%D 2020
%Z 2020 Apr;196(4):334-348#LA:E055#
%X Retrospective evaluation of stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma (HCC).We retrospectively analyzed 36 patients (45 lesions) treated between 2011 and 2017. Twenty-seven had previous treatments. Current treatment consisted of SBRT alone (n = 15) or selective transarterial chemoembolization (TACE) followed by SBRT to the same lesions (n = 21). Eight patients received additional local treatments to different lesions. Liver function was predominantly moderately restricted (Child A: 29, Child B: 6, Child C: 1). Treatment planning was based on 4D-computed tomography, dose/fractionation varied depending on location and size, most commonly 3 fractions of 12.5 Gy (65
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:31732784
%R 10.1007/s00066-019-01540-8
%U https://inrepo02.dkfz.de/record/147645